Drug name - Advair Hfa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7832351 GLAXO GRP LTD Actuation indicator for a dispensing device Jun, 2023

(8 months from now)

US7832351

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device Dec, 2023

(1 year, 2 months from now)

US7500444 GLAXO GRP LTD Actuation indicator for a dispensing device Feb, 2026

(3 years from now)

US7500444

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device Aug, 2026

(3 years from now)

More Information on Dosage
Strength Dosage Availability
0.045MG/INH;EQ 0.021MG BASE/INH AEROSOL, METERED;INHALATION Prescription
0.115MG/INH;EQ 0.021MG BASE/INH AEROSOL, METERED;INHALATION Prescription
0.23MG/INH;EQ 0.021MG BASE/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.